ClinicalTrials.Veeva

Menu

Effects of Very Low Calorie Diet vs Metabolic Surgery on Weight Loss and Obesity Comorbidities (ARGOS)

C

Catholic University of the Sacred Heart

Status

Unknown

Conditions

Bariatric Surgery Candidate
Obesity
Diet, Healthy
Obesity, Morbid

Treatments

Behavioral: Very low calorie diet with Fortimel (Nutricia) supplementation
Procedure: Metabolic Surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT04583683
20203009

Details and patient eligibility

About

It is a prospective randomized trial on 218 subjects, 109 for each arms. The purpose of this trial is to compare very low calorie diet and metabolic surgery induced weight loss and its maintenance.

Full description

Obesity is a leading public health issued associated with poor quality of life, morbidity and an increased mortality rate. Although metabolic surgery results in a greater weight loss when compared to non-surgical approaches, a low calorie diet associated with intensive maintenance session may be a valid alternative for weight loss. Since lifestyle interventions are safer and potentially more cost effective than metabolic surgery, this trial will test whether an intensive lifestyle intervention is as effective as metabolic surgery to induce weight loss and its maintenance.

A total of 218 participants will be randomly assigned to metabolic surgery (109) or intensive lifestyle intervention (109).

Clinical outcomes will be assessed at 25% reduction in Body Mass Index (BMI), at 12 months and 24 months.

Enrollment

218 patients

Sex

All

Ages

19 to 69 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged between 19 and 69 years
  • Body Mass Index ≥35 kg/m2 and at least one or more obesity-related co-morbidities such as type II diabetes (T2DM), hypertension, sleep apnea and other respiratory disorders, non-alcoholic fatty liver disease, osteoarthritis, lipid abnormalities, gastrointestinal disorders, or heart disease
  • Body Mass Index ≥40 kg/m2

Exclusion criteria

  • Pregnancy
  • Active cancer
  • End stage renal failure
  • End stage liver failure
  • Being unable to understand and sign informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

218 participants in 2 patient groups

Intensive lifestyle modification: Very low calorie diet
Active Comparator group
Description:
Patients will undergo a very low calorie diet
Treatment:
Behavioral: Very low calorie diet with Fortimel (Nutricia) supplementation
Metabolic Surgery
Active Comparator group
Description:
Patients will undergo metabolic surgery
Treatment:
Procedure: Metabolic Surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems